Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Judith Kirstein, Miriam Pina, Judy Pan, Emilia Jordanov & Mandeep S. Dhingra. (2020) Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study. Human Vaccines & Immunotherapeutics 16:6, pages 1299-1305.
Read now
Read now
Tea Burmaz, Stefano Guicciardi, Vittorio Selle, Pier Luigi Lopalco, Vincenzo Baldo & Maria Pia Fantini. (2019) Management of meningococcal outbreaks: are we using the same language? Comparison of the public health policies between high-income countries with low incidence of meningococcal disease. Expert Review of Vaccines 18:5, pages 559-574.
Read now
Read now
A. W. Dretler, N. G. Rouphael & D. S. Stephens. (2018) Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development. Human Vaccines & Immunotherapeutics 14:5, pages 1146-1160.
Read now
Read now
Rouba Shaker, Danielle Fayad & Ghassan Dbaibo. (2018) Challenges and opportunities for meningococcal vaccination in the developing world. Human Vaccines & Immunotherapeutics 14:5, pages 1084-1097.
Read now
Read now
Helen Petousis-Harris. (2018) Impact of meningococcal group B OMV vaccines, beyond their brief. Human Vaccines & Immunotherapeutics 14:5, pages 1058-1063.
Read now
Read now
Giulia Piccini, Alessandro Torelli, Elena Gianchecchi, Simona Piccirella & Emanuele Montomoli. (2016) Fighting Neisseria meningitidis: past and current vaccination strategies. Expert Review of Vaccines 15:11, pages 1393-1407.
Read now
Read now
Aia Assaf-Casals & Ghassan Dbaibo. (2016) Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence. Human Vaccines & Immunotherapeutics 12:7, pages 1825-1837.
Read now
Read now
Cosmina Hogea, Thierry Van Effelterre & Andrew Vyse. (2016) Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement. Human Vaccines & Immunotherapeutics 12:2, pages 451-466.
Read now
Read now
Articles from other publishers (18)
Andrea Conti, Gaia Broglia, Chiara Sacchi, Fabrizia Risi, Francesco Barone-Adesi & Massimiliano Panella. (2023) Efficacy and Safety of Quadrivalent Conjugate Meningococcal Vaccines: A Systematic Review and Meta-Analysis. Vaccines 11:1, pages 178.
Crossref
Crossref
Mark R. Alderson, Jo Anne Welsch, Katie Regan, Lauren Newhouse, Niranjan Bhat & Anthony A. Marfin. (2021) Vaccines to Prevent Meningitis: Historical Perspectives and Future Directions. Microorganisms 9:4, pages 771.
Crossref
Crossref
Laura M. Reyes Díaz, Miriam de S.J.B. Lastre González, Maribel Cuello, V. Gustavo Sierra-González, Raúl Ramos Pupo, Maria Isela Lantero, Ali M. Harandi, Steven Black & Oliver Pérez. (2021) VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of Gonorrhea. Pediatric Infectious Disease Journal 40:4, pages 375-381.
Crossref
Crossref
Nikita Pozdeyev, Arpit Patel, Paul S. Pottinger, Michael Leu & Thomas H. Payne. (2020) Adherence to Recommended Post-Splenectomy Immunizations to Reduce the Risk of Sepsis: The University of Washington Experience. American Journal of Medical Quality 35:5, pages 405-410.
Crossref
Crossref
Alastair McAlpine & Manish Sadarangani. (2019) Meningitis vaccines in children. Current Opinion in Infectious Diseases 32:5, pages 510-516.
Crossref
Crossref
Cong Hung Phan, Thi Phuong Thuy Nguyen, Uyen Y. Doan, Thuy An Nguyen, Yaël Thollot & Maria Carmen Nievera. (2019) Safety of a quadrivalent meningococcal conjugate vaccine in healthy subjects aged 9 months to 55 years in Vietnam. Pharmacoepidemiology and Drug Safety 28:4, pages 515-520.
Crossref
Crossref
Gabriela Trzewikoswki de Lima, Amanda Izeli Portilho & Elizabeth De Gaspari. (2019)
Cross-reactivity with Brazilian strains of
Neisseria meningitidis
B after immunization with outer membrane vesicles
. Therapeutic Advances in Vaccines and Immunotherapy 7, pages 251513551989482.
Crossref
Crossref
Jose Manuel Merino Arribas, Alfonso Carmona Martínez, Michael Horn, Xavier Maria Perez Porcuna, Maria del Carmen Otero Reigada, Josep Marès Bermúdez, Fernando Centeno Malfaz, Mariano Miranda, Maria Mendez, Miguel Angel Garcia Cabezas, Wittermann Christoph, Gerhard Bleckmann, Thomas Fischbach, Devayani Kolhe, Marie Van der Wielen & Yaela Baine. (2018) Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib and PHiD-CV When Coadministered With MenACWY-TT in Infants. Pediatric Infectious Disease Journal 37:7, pages 704-714.
Crossref
Crossref
Patrizio Pezzotti, Alessandro Miglietta, Arianna Neri, Cecilia Fazio, Paola Vacca, Fabio Voller, Giovanni Rezza & Paola Stefanelli. (2018) Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy. Vaccine 36:29, pages 4222-4227.
Crossref
Crossref
Luis Rivera, Tino F. Schwarz, Kyung-Hyo Kim, Yun-Kyung Kim, Ulrich Behre, Sung-Ho Cha, Dae Sun Jo, Jacob Lee, Jin-Soo Lee, Brigitte Cheuvart, Archana Jastorff & Marie Van der Wielen. (2018) Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study. Vaccine 36:31, pages 4750-4758.
Crossref
Crossref
Tsitsi D. Mubaiwa, Lauren E. Hartley-Tassell, Evgeny A. Semchenko, Christopher J. Day, Michael P. Jennings & Kate L. Seib. (2018) The Bexsero Neisseria meningitidis serogroup B vaccine antigen NHBA is a high-affinity chondroitin sulfate binding protein. Scientific Reports 8:1.
Crossref
Crossref
Nancy Crum-Cianflone & Eva Sullivan. (2016) Meningococcal Vaccinations. Infectious Diseases and Therapy 5:2, pages 89-112.
Crossref
Crossref
Rhonda J. Hammerquist, Kimberly A. Messerschmidt, April A. Pottebaum & Thaddaus R. Hellwig. (2016) Vaccinations in asplenic adults. American Journal of Health-System Pharmacy 73:9, pages e220-e228.
Crossref
Crossref
William Johnston, Brandon Essink, Judith Kirstein, Eduardo Forleo-Neto, Sandra Percell, Linda Han, Pavitra Keshavan & Igor Smolenov. (2016) Comparative Assessment of a Single Dose and a 2-dose Vaccination Series of a Quadrivalent Meningococcal CRM-conjugate Vaccine (MenACWY-CRM) in Children 2–10 Years of Age. Pediatric Infectious Disease Journal 35:1, pages e19-e27.
Crossref
Crossref
Charissa Fay Corazon Borja-Tabora, Cecilia Montalban, Ziad A. Memish, Dominique Boutriau, Devayani Kolhe, Jacqueline M. Miller & Marie Van der Wielen. (2015) Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial. BMC Infectious Diseases 15:1.
Crossref
Crossref
Silvia Fallarini, Benedetta Buzzi, Sara Giovarruscio, Laura Polito, Giulia Brogioni, Marta Tontini, Francesco Berti, Roberto Adamo, Luigi Lay & Grazia Lombardi. (2015)
A Synthetic Disaccharide Analogue from
Neisseria meningitidis
A Capsular Polysaccharide Stimulates Immune Cell Responses and Induces Immunoglobulin G (IgG) Production in Mice When Protein-Conjugated
. ACS Infectious Diseases 1:10, pages 487-496.
Crossref
Crossref
Martine P. Bos, Ria Tommassen-van Boxtel & Jan Tommassen. 2015. The BAM Complex. The BAM Complex
33
49
.
Barbara C. Gärtner & Tim Meyer. (2014) Vaccination in Elite Athletes. Sports Medicine 44:10, pages 1361-1376.
Crossref
Crossref